These Mass. Companies Are Developing COVID-19 Treatments and Tests

NBCUniversal, Inc.

More than two dozen Massachusetts companies have announced plans to create vaccines, treatments or devices for COVID-19 — garnering attention from investors but raising questions about long-term success. 

Atlas Venture Partner Kevin Bitterman said during a virtual LabCentral discussion Tuesday that it would be “almost criminal” for venture capital firms and their portfolio companies not to consider turning their attention to the development of COVID-19 products. His firm is encouraging its startups to consider development of preventative or therapeutic drugs.

That sentiment is trickling down through the public and private markets.

Read more at Boston Business Journal.

Copyright Boston Business Journal
Contact Us